Fansa H, Keilhoff G, Altmann S, Plogmeier K, Wolf G, Schneider W
Department of Plastic, Reconstructive and Hand Surgery, and the Institute of Medical Neurobiology, University of Magdeburg, Germany.
J Hand Surg Br. 1999 Feb;24(1):38-42. doi: 10.1016/s0266-7681(99)90021-9.
Nerve allografts are highly antigenic and require the continuous use of immunosuppressive drugs. Neurotoxic complications from immunosuppressant therapy with FK 506 have been noted in the central and peripheral nervous system although an increased rate of axonal regeneration has also been noted. Regeneration of peripheral nerve grafts was assessed in a rat model clinically and morphometrically after treatment for 2 and 6 weeks with two different doses of FK 506. Good regeneration was noted in all groups at 6 weeks. A significantly higher axon count was observed in both the FK 506 groups after 2 weeks regeneration compared with controls. This beneficial effect was not evident after 6 weeks of regeneration. Whether this is related to a pruning mechanism or to a down-regulation of regenerative processes in the nerve due to possible neurotoxic effects of FK 506 remains unknown.
神经同种异体移植具有高度抗原性,需要持续使用免疫抑制药物。尽管也观察到轴突再生率有所提高,但使用FK 506进行免疫抑制治疗时,在中枢和外周神经系统均已发现神经毒性并发症。在用两种不同剂量的FK 506治疗2周和6周后,在大鼠模型中对周围神经移植的再生情况进行了临床和形态学评估。6周时所有组均观察到良好的再生。与对照组相比,在再生2周后,两个FK 506组的轴突计数均显著更高。在再生6周后,这种有益效果并不明显。这是否与修剪机制有关,或者是否由于FK 506可能的神经毒性作用导致神经再生过程的下调,目前尚不清楚。